PDS Biotechnology Corporation Profile Avatar - Palmy Investing

PDS Biotechnology Corporation

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment fo…

Biotechnology
US, Florham Park [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of PDSB's Analysis
CIK: 1472091 CUSIP: 70465T107 ISIN: US70465T1079 LEI: - UEI: -
Secondary Listings
PDSB has no secondary listings inside our databases.